Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 326 to 350
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period - melatonin
-
PublicationsThe TGA 2019-20 Annual Performance Statistics Report has now been published.
-
PublicationsThis Regulation Impact Statement (RIS) is intended to assist the Australian Government in reaching a decision to address the issues relating to the safe use of sports supplements in Australia.
-
Scheduling submissionsPublic submissions on scheduling matters referred to the Joint ACMS-ACCS #25 meetings held in June 2020 - Nicotine
-
Scheduling submissionsPublic submissions made in response to the proposed amendments to the Poisons Standard referred to the ACMS #31 and Joint ACMS-ACCS #25 meetings held in June 2020
-
PublicationsOverview of therapeutic goods advertising complaints handling and compliance for 2019-20
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 13 October 2020
-
Meeting statementsA meeting of the TGACC was held on 27 August 2020. A communique has been published.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
TGA laboratory testing reportsTGA Laboratories has released a new report describing our assessment of the 2020 seasonal flu vaccine
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the Poisons Standard.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 16 July 2020
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Scheduling decisions (interim)Invitation for further comment. Closing date: 28 August 2020
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
PublicationsThe independent review is complete and the report now published.
-
PublicationsFinal Report on the impact of advertising reforms from the Expert Panel Review of Medicines and Medical Devices Regulation, and other initiatives
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement